Molecular approaches to renal physiology and therapeutics

Seminars in Nephrology

Volumn 18, Issue 2, 1998, Pages 102-121

  Kone, Bruce C ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

GENE INDUCTION; GENE MUTATION; GENE TARGETING; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC TRANSFORMATION; HUMAN; KIDNEY DISEASE; KNOCKOUT MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE;

ANIMALS; DISEASE MODELS, ANIMAL; GENE TRANSFER TECHNIQUES; HUMANS; KIDNEY; KIDNEY DISEASES; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; TRANSGENES;

EID: 0031952628     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (149)

1. Ganz MB, Albrightson C: Experience with antisense oligodeoxynucleotides in renal cells. Exp Nephrol 5:175-179, 1997
2. Imai E, Isaka Y, Akagi Y, Kaneda Y: Gene transfer into the glomerulus by the hemagglutinating virus of Japan liposome method. Exp Nephrol 5:112-117, 1997
3. Kelly VR, Moore KJ: Application of a gene transfer strategy to identify molecules that incite autoimmune kidney injury. Exp Nephrol 5:144-151, 1997
4. Kitamura M: Gene delivery into the glomerulus via mesangial cell vectors. Exp Nephrol 5:118-125, 1997
5. Kopp JB: Gene expression in kidney using transgenic approaches. Exp Nephrol 5:157-167, 1997
6. Lien YH, Lai LAV: Liposome mediated gene transfer into the tubules. Exp Nephrol 5:132-136, 1997
7. Matsusaka T, Ichikawa I: Gene targeting in nephrology. Exp Nephrol 5:168-173, 1997
8. Ryffel B: Gene knockout mice as investigative tools in pathophysiology. Int J Exp Pathol 77:125-141, 1996
9. Sukhatme VP, Cowley BD, Zhu G: Gene transfer into kidney tubules and vasculature by adenoviral vectors. Exp Nephrol 5:137-143, 1997
10. Lipkowitz MS, Klotman ME, Bruggeman LA, et al: Molecular therapy for renal diseases. Am J Kidney Dis 28:475-492, 1996
11. Kistner A, Gossen M, Zimmermann F, et al: Doxycycline-mediated quantitative and tissue specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 93:10933-10938, 1996
12. Baron U, Gossen M, Bujard H: Tetracycline-controlled transcription in eukaryotes: Novel transactivators with graded transactivation potential. Nucleic Acids Res 25:2723-2729, 1997
13. Passman RS, Fishman GI: Regulated expression of foreign genes in vivo after germline transfer. J Clin Invest 94:2421-2425, 1994
14. Furth PA, St Onge L, Boger H, et al: Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA 91:9302-9306, 1994
15. Gossen M, Freundlieb S, Bender G, et al: Transcriptional activation by tetracyclines in mammalian cells. Science 268:1766-1769, 1995
16. Kimura S, Mullins JJ, Bunnemann B, et al: High blood pressure in transgenic mice carrying the rat angiotensinogen gene. Embo J 11:821-827, 1992
17. Wang DZ, Chao L, Chao J: Hypotension in transgenic mice overexpressing human bradykinin B2 receptor. Hypertension 29:488-493, 1997
18. Dressler GR, Wilkinson JE, Rothenpieler UW, et al: Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities. Nature 362:65-67, 1993
19. Samama P, Bond RA, Rockman HA, et al: Ligand induced overexpression of a constitutively active β2 adrenergic receptor: Pharmacological creation of a phenotype in transgenic mice. Proc Natl Acad Sci USA 94:137-141, 1997
20. Korzick DH, Xiao RP, Ziman BD, et al: Transgenic manipulation of beta adrenergic receptor kinase modifies cardiac myocyte contraction to norepinephrine. Am J Physiol 272:H590-596, 1997
21. +-ATPase β subunit. Am J Physiol 268:F363-374, 1995
22. Haidar MA, Loya F, Yang Y, et al: Electron microscopic localization of lacZ expression in the proximal convoluted tubular cells of the kidney in transgenic mice carrying chimeric erythropoietin/lacZ gene constucts. J Struct Biol 118:220-225, 1997
23. Loya F, Yang Y, Lin H, et al: Transgenic mice carrying the erythropoietin gene promoter linked to lacZ express the reporter in proximal convoluted tubule cells after hypoxia. Blood 84:1831-1836, 1994
24. Madan A, Lin C, Hatch SLn, Curtin PT: Regulated basal, inducible, and tissue-specific human erythropoietin gene expression in transgenic mice requires multiple cis DNA sequences. Blood 85:2735-2741, 1995
25. Maxwell PH, Osmond MK, Pugh CW, et al: Identification of the renal erythropoietin producing cells using transgenic mice. Kidney Int 44:1149-1162, 1993
26. Price PM, Megyesi J, Saggi S, Safirstein RL: Regulation of transcription by the rat EOF gene promoter in normal and ischemic murine kidney cells. Am J Physiol 268:F664-670, 1995
27. Palmiter R, Behringer R, Quaife C, et al: Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene. Cell 50:435-443, 1987
28. Bruggeman LA, Dikman S, Meng C, et al: Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clin Invest 100:84-92, 1997
29. De Paepe ME, Trudel M: The transgenic SAD mouse: A model of human sickle cell glomerulopathy. Kidney Int 46:1337-1345, 1994
30. Fattori E, Delia Rocca C, Costa P, et al: Development of progressive kidney in interleukin-6 transgenic mice. Blood 83:2570-2579, 1994
31. Evans MJ, Kaufman MH: Establishment in culture of pluripotential cells from mouse embryos. Nautre 292:154-156, 1981
32. Martin G: Isolation of a pluripotent cell line from early embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci 78:7634-7638, 1981
33. Smithies O, Gregg R, Boggs S, et al: Insertion of DNA sequences into the human chromsomal β-globin locus by homologous recombination. Nature 317:230-234, 1985
34. Nishimura H, Matsusaka T, Fogo A, et al: A novel in vivo mechanism for angiotensin type 1 receptor regulation. Kidney Int 52:345-355, 1997
35. Cosgrove D, Meehan DT, Grunkemeyer JA, et al: Collagen COMAS knockout: a mouse model for autosomal Alport syndrome. Genes Dev 10:2981-2992, 1996
36. Ohshima T, Murray GJ, Swaim WD, et al: α-Galactosidase A deficient mice: A model of Fabry disease. Proc Natl Acad Sci 94:2540-2544, 1997
37. Engle SJ, Stockelman MG, Chen J, et al: Adenine phosphoribosyltransferase-deficient mice develop 2,8 dihydroxyadenine nephrolithiasis. Proc Natl Acad Sci USA 93:5307-5312, 1996
38. Ho C, Conner DA, Pollak MR, et al: A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet 11:389-394, 1995
39. Shesely EG, Maeda N, Kirn HS, et al: Elevated blood pressures in mice lacking endothelial mitric oxide synthase. Proc Natl Acad Sci 93:13176-13181, 1996
40. Ma T, Yang B, Gillespie A, et al: Generation and phenotype of a transgenic knockout mouse lacking the mercurial-insensitive water channel aquaporin 4. J Clin Invest 100:957-962, 1997
41. Hosoda KRH, Richardson J, Baynash A, et al: Targeted and natural (piebald-lethal) mutatons of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell 79:1267-1276, 1994
42. Davisson RL, Kim HS, Krege JH, et al: Complementation of reduced survival, hypotension, and renal abnormalities in angiotensinogen-deficient mice by the human renin and human angiotensinogen genes. J Clin Invest 99:1258-1264, 1997
43. Haas C, Ryffel B, Le Hir M: IFN-y is essential for the development of autoimmune glomerulonephritis in MRL/ Ipr mice. J Immunol 158:5484-5491, 1997
44. Son H, Hawkins RD, Martin K, et al: Long term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase. Cell 87:1015-1023, 1996
45. Dinchuk JE, Car BD, Focht RJ, et al: Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase-II. Nature 378:406-409, 1995
46. Sternberg N, Hamilton D: Bacteriophage PI site-specific recombination. I. Recombination between loxP sites. J Mol Biol 150:467-486, 1981
47. Dymecki SM: Flp recombinase promotes site-specific DNA recombination in embryonic stem cells and transgenic mice. Proc Natl Acad Sci 93:6191-6196, 1996
48. O'Gorman S, Fox DT, Wahl GM: Recombinase-mediated gene activation and site-specific integration in mammalian cells. Science 251:1351-1355, 1991
49. Feil R, Brocard J, Mascrez B, et al: Ligand-activated site specific recombination in mice. Proc Natl Acad Sci 93:10887-10890, 1996
50. Kuhn R, Schwenk F, Aguet M, Rajewsky K: Inducible gene targeting in mice. Science 269:1427-1429, 1995
51. Shibata H, Toyama K, Shioya H, et al: Rapid colorectal adenoma formation initiated by conditional targeting of the APC gene. Science 278:120-123, 1997
52. Agah R, Frenkel PA, French BA, et al: Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J Clin Invest 100:169-179, 1997
53. Marshall E: The mouse that prompted a roar. Science 277:24-25, 1997
54. O'Gorman S, Wahl GM: Mouse engineering. Science 277:1025, 1997
55. Isaka Y, Fujiwara T, Ueda N, et al: Glomerulosclerosis induced by in vivo transfection of transforming growth factor beta of platelet derived growth factor gene into the rat kidney. J Clin Invest 92:2597-2601, 1993
56. Aral M,. Wada A, Isaka Y, et al: In vivo transfection of genes for renin and angiotensinogen into the glomerular cells induced phenotypic change of the mesangial cells and glomerular sclerosis. Biochem Biophys Res Commun 206:525-532, 1995
57. Zhu G, Nicolson AG, Cowley BD, et al: In vivo adenovirus-mediated gene transfer into normal and cystic rat kidneys. Gene Ther 3:298-304, 1996
58. Zeigler ST, Kerby JD, Curiel DT, et al: Molecular conjugate-mediated gene transfer into isolated human kidneys. Transplantation 61:812-817, 1996
59. Naito T, Yokoyama H, Moore KJ et al: Macrophage growth factors introduced into the kidney initiate renal injury. Mol Med 2:297-312, 1996
60. Naito T, Yokoyama H, Moore KJ, et al: A gene transfer system establishes interleukin-6 neither promotes nor suppresses renal injury. Am J Physiol 271:F603-609, 1996
61. Moore KJ, Naito T, Martin C, Kelley VR: Enhanced response of macrophages to CSF-1 in autoimmune mice: A gene transfer strategy. J Immunol 157:433-440, 1996
62. Flotte T, Carter B, Conrad C, et al: A phase I study of an adeno-associated virus CFTR gene vector in adult CF patients with mild lung disease. Hum Gene Ther 7:1145-1159, 1996
63. Kitamura M, Taylor S, Unwin R, et al: Gene transfer into the rat renal glomerulus via a mesangial cell vector: Site-specific delivery, in situ amplification, and sustained expression of an exogenous gene in vivo. J Clin Invest 94:497-505, 1994
64. Yokoo T, Kitamura M: Gene transfer of interleukin1 receptor antagonist into the renal glomerulus via a mesangial cell vector. Biochem Biophys Res Commun 226:883-888, 1996
65. Kitamura M, Burton S, Yokoo T, Fine LG: Gene delivery into the renal glomerulus by transfer of genetically engineered, autologous mesangial cells. Exp Nephrol 4:56-59, 1996
66. Kitamura M: Creation of a reversible on/off system for site-specific in vivo control of exogenous gene activity in the renal glomerulus. Proc Natl Acad Aci 93:7387-7391, 1996
67. Kitamura M, Kawachi H: Creation of an in vivo cytosensor using engineered mesangial cells. Automatic sensing of glomerular inflammation controls transgene activity. J Clin Invest 100:1394-1399, 1997
68. lyer SN, Lu D, Katovich MJ, Raizada MK: Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense. Proc Natl Acad Sci 93:9960-9965, 1996
69. Campbell J, Bacon T, Wickstrom E: Oligodeoxynucleotide phosphorothioate stability in subcellular extracts, culture media, sera and cerebrospinal fluid. J Biochem Biophys Methods 20:259-267, 1990
70. Stein C: Exploiting the potential of antisense: Beyond phosphorothioate oligodeoxynucleotides. Chem Biol 3:319323, 1996
71. Carome MA, Kang YH, Bohen EM, et al: Distribution of the cellular uptake of phosphorothioate oligodeoxynucleotides in the rat kidney in vivo. Nephron 75:82-87, 1997
72. +/Pi cotransporter by antisense oligonucleotides. Proc Natl Acad Sci 93:4903-4906, 1996
73. Lai LW, Moeckel GW, Lien YH: Kidney-targeted liposome-mediated gene transfer in mice. Gene Ther 4:426-431, 1997
74. Akagi Y, Isaka Y, Arai M, et al: Inhibition of TGF-β1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 50:148-155, 1996
75. Mattson DL, Bellehumeur TG: Neural nitric oxide synthase in the renal medulla and blood pressure regulation. Hypertension 28:297-303, 1996
76. Noiri E, Peresleni T, Miller F, Goligorsky MS: In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J Clin Invest 97:2377-2383, 1996
77. Haller H, Dragun D, Miethke A, et al: Antisense oligonucleotides for ICAM-1 attenuate reperfusion injury and renal failure in the rat. Kidney Int 50:473-480, 1996
78. Morishita R, Sugimoto T, Aoki M, et al: In vivo transfection of cis-element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction. Nat Med 3:894-899, 1997
79. Yamada T, Horiuchi M, Morishita R, et al: In vivo identification of a negative regulatory element in the mouse renin gene using direct gene transfer. J Clin Invest 96:1230-1237, 1995
80. Akagi Y, Isaka Y, Akagi A, et al: Transcriptional activation of a hybrid promoter composed of cytomegalovirus enhancer and beta actin/beta globin gene in glomerular epithelial cells in vivo. Kidney Int 51:1265-1269, 1997
81. Vicart P, Schwanz B, Vandewalle A, et al: Immortalization of multiple cell types from transgenic mice using a transgene containing the vimentin promoter and a conditional oncogene. Exp Cell Res 214:35-45, 1994
82. Cowan PJ, Shinkel TA, Witort EJ, et al: Targeting gene expression to endothelial cells in transgenic mice using the human intercellular adhesion molecule-2 promoter. Transplantation 62:155-160, 1996
83. Aird WC, Jahroudi N, Weiler Guettler H, et al: Human von Willebrand factor gene sequences target expression to a subpopulation of endothelial cells in transgenic mice. Proc Natl Acad Sci 92:4567-4571, 1995
84. Harats D, Kurihara H, Belloni P, et al: Targeting gene expression to the vascular wall in transgenic mice using the murine preproendothelin-1 promoter. J Clin Invest 95:1335-1344, 1995
85. Sepulveda AR, Huang SL, Lebovitz RM, Lieberman MW: A 346 base pair region of the mouse gamma glutamyl transpeptidase type II promoter contains sufficient m-acting elements for kidney restricted expression in transgenic mice. J Biol Chem 272:11959-11967, 1997
86. Yang G, Merrill DC, Thompson MW, et al: Functional expression of the human angiotensinogen gene in transgenic mice. J Biol Chem 269:32497-32502, 1994
87. Short MK, Clouthier DE, Schaefer IM, et al: Tissue specific, developmental, hormonal, and dietary regulation of rat phosphoenolpyruvate carboxykinase human growth hormone fusion genes in transgenic mice. Mol Cell Biol 12:1007-1020, 1992
88. Igarashi P, Whyte DA, Li K, Nagami GT: Cloning and kidney cell-specific activity of the promoter of the murine renal Na-K-Cl contransporter gene. J Biol Chem 271:9666-9674, 1996
89. Blau S, Daly L, Fienberg A, et al: DARPP-32 promoter directs transgene expression to renal thick ascending limb of loop of Henle. Am J Physiol 269:F564-570, 1995
90. Yu H, Papa F, Sukhatme VP: Bovine and rodent Tamm-Horsfall protein (TUP) genes: Cloning,. structural analysis, and promoter identification. Gene Expr 4:63-75, 1994
91. Thorey IS, Cecena G, Reynolds W, Oshima RG: Alu sequence involvement in transcriptional insulation of the keratin 18 gene in transgenic mice. Mol Cell Biol 13:6742-6751, 1993
92. Palmiter RD, Sandgren EP, Koeller DM, Brinster RL: Distal regulatory elements from the mouse metallothionein locus stimulate gene expression in transgenic mice. Mol Cell Biol 13:5266-5275, 1993
93. Kaneko T, Takenaka M, Okabe M, et al: Osmolarity in renal medulla of transgenic mice regulates transcription via 5' flanking region of canine BGT1 gene. Am J Physiol 272:F610-616, 1997
94. Fukamizu A, Hatae T, Kon Y, et al: Human renin in transgenic mouse kidney is localized to juxtaglomerular cells. Biochem J 278:601-603, 1991
95. McCuaig KA, Lee HS, Clarke JC, et al: Parathyroid hormone/parathyroid hormone related peptide receptor gene transcripts are expressed from tissue specific and ubiquitous promoters. Nucleic Acids Res; 23:1948-1955, 1995
96. +/phosphate cotransporter. Biochem J 324:927-934, 1997
97. Chen LM, Ma J, Liang YM, et al: Tissue kallikrein binding protein reduces blood pressure in transgenic mice. J Biol Chem 271:27590-27594, 1996
98. +-proton exchanger. Circ Res 76:148-153, 1995
99. Veress AT, Chong CK, Field LJ, Sonnenberg H: Blood pressure and fluid electrolyte balance in ANF transgenic mice on high and low salt diets. Am J Physiol 269:R186-192, 1995
100. Sonnenberg H, Honrath U, Chong CK, et al: Proximal tubular function in transgenic mice overexpressing atrial natriuretic factor. Can J Physiol Pharmacol 72:1168-1170, 1994
101. Veniant M, Menard J, Bruneval P, et al: Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver. J Clin Invest 98:1966-1970, 1996
102. Bohlender J, Menard J, Wagner J, et al: Human renindependent hypertension in rats transgenic for human angiotensinogen. Hypertension; 27:535-540, 1996
103. Springate J, Van Liew J, Ganten D: Enalapril and pressure diuresis in hypertensive rats transgenic for mouse renin gene. Kidney Blood Press Res 20:1-5, 1997
104. Hocher B, Thone Reineke C, Rohmeiss P, et al: Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. J Clin Invest 99:1380-1389, 1997
105. Hocher B, Liefeldt L, Thone Reineke C, et al: Characterization of the renal phenotype of transgenic rats expressing the human endothelin-2 gene. Hypertension 28:196-201, 1996
106. Lowden DA, Lindemann GW, Merlino G, et al: Renal cysts in transgenic mice expressing transforming growth factor-a. J Lab Clin Mcd 124:386-394, 1994
107. Kopp JB, Factor VM, Mozes M, et al: Transgenic mice with increased plasma levels of TGF-β1 develop progressive renal disease. Lab Invest 74:991-1003, 1996
108. Yang CV, Striker LJ, Kopchick JJ, et al: Glomerulosclerosis in mice transgenic for native or mutated bovine growth hormone gene. Kidney Int 39:590-94, 1993 (Suppl)
109. Yang CW, Striker GE, Chen WY, et al: Differential expression of glomerular extracellular matrix and growth factor mRNA in rapid and slowly progressive glomerulosclerosis: studies in mice transgenic for native or mutated growth hormone. Lab Invest 76:467-476, 1997
110. Takayama H, LaRochelle WJ, Sabnis SG, et al: Renal tubular hyperplasia, polycystic disease, and glomerulosclerosis in transgenic mice overexpressing hepatocyte growth factor/scatter factor. Lab Invest 77:131-138, 1997
111. Godley LA, Kopp JB, Eckhaus M, et al: Wild type p53 transgenic mice exhibit altered differentiation of the ureteric bud and possess small kidneys. Genes Dev 10:836-850, 1996
112. Zhang L, Eddy A, Teng YT, et al: An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes. Mol Cell Biol 15:6961-6970, 1995
113. Hsu HC, Zhou T, Yang PA, et al: Increased acute phase response and renal amyloidosis in aged CD2 fas transgenic mice. J Immunol 158:5988-5996, 1997
114. Erb KJ, Ruger B, von Brevern M, et al: Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune type disorders in mice. J Exp Med 185:329-339, 1997
115. Fabry ME, Constantini F, Pachnis A, et al: High expression of human beta S and alpha globins in transgenic mice: Erythrocyte abnormalities, organ damage, and the effect of hypoxia, Proc Natl Acad Sci 89:12155-12159, 1992
116. Kopp JB, Klotman ME, Adler SH, et al: Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc Natl Acad Sci 89:1577-1581, 1992
117. McCurry KR, Kooyman DL, Diamond LE, et al: Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion. Transplantation 59:1177-1182, 1995
118. Daggett CW, Yeatman M, Lodge AJ, et al: Swine lungs expressing human complement regulatory proteins are protected against acute pulmonary dysfunction in a human plasma perfusion model. J Thorac Cardiovasc Surg 113:390-398, 1997
119. Byrne GW, McCurry KR, Martin MJ, et al: Transgenic pigs expressing human CD59 and decay accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 63:149-155, 1997
120. MacKay K, Striker LJ, Pinkert A, et al: Glomerulosclerosis and renal cysts in mice transgenic for the early region of SV40. Kidney Int 32:827-837, 1987
121. Alfie ME, Yang XP, Hess F, Carretero OA: Saltsensitive hypertension in bradykinin B2 receptor knockout mice. Biochem Biophys Res Commun 224:625-630, 1996
122. Alfie ME, Sigmon DH, Pomposiello SI, Carretero OA: Effect of high salt intake in mutant mice lacking bradykinin B2 receptors. Hypertension 29:483-487, 1997
123. John SW, Krege JH, Oliver PM, et al: Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267:679-681, 1995
124. John SW, Veress AT, Honrath U, et al: Blood pres-sure and fluid electrolyte balance in mice with reduced or absent ANP. Am J Physiol 271:R109-114, 1996
125. Lopez MJ, Wong SK, Kishimoto I, et al: Salt-resistant hypertension in mice lacking the guanylyl cyclase A receptor for atrial natriuretic peptide. Nature 378:65-68, 1995
126. Niimura F, Labosky PA, Kakuchi J, et al: Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J Clin Invest 96:2947-2954, 1995
127. Tanimoto K, Sugiyama F, Goto Y, et al: Angiotensinogen-deficient mice with hypotension. J Biol Chem 269:31334-31337, 1994
128. Nagata M, Tanimoto K, Fukamizu A, et al: Nephrogenesis and renovascular development in angiotensinogendeficient mice. Lab Invest 75:745-753, 1996
129. Hilgers KF, Reddi V, Krege JH, et al: Aberrant renal vascular morphology and renin expression in mutant mice lacking angiotensin converting enzyme. Hypertension 29:216-221, 1997
130. Clark AF, Sharp MGF, Morley SD, et al: Renin-1 is essential for normal renal juxtaglomerular cell granulation and macula densa morphology. J Biol Chem 272:18185-18190, 1997
131. Oliverio MI, Best CF, Kim HS, et al: Angiotensin II responses in ATI A receptor deficient mice: A role for AT1B receptors in blood pressure regulation. Am J Physiol 272:F515-520, 1997
132. Sugaya T, Nishimatsu S, Tanimoto K, et al: Angiotensin II type la receptor deficient mice with hypotension and hyperreninemia. J Biol Chem 270:18719-18722, 1995
133. Chen X, Li V, Yoshida H, et al: Targeting deletion of angiotensin type IB receptor gene in the mouse. Am J Physiol 272:F299-304, 1997
134. Ichiki T, Labosky PA, Shiota C, et al: Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type 2 receptor. Nature 377:748-750, 1995
135. Hein L, Barsh GS, Pratt RE, et al: Behavioural and cardiovascular effects of disrupting the angiotensin II type receptor in mice. Nature 377:744-747, 1995
136. Huang PL, Huang Z, Mashimo H, et al: Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377:239-242, 1995
137. Steudel W, Ichinose F, Huang PL, et al: Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene. Circ Res 81:34-41, 1997
138. Schulz JB, Huang PL, Matthews RT, et al: Striatal malonate lesions are attenuated in neuronal nitric oxide synthase knockout mice. J Neurochem 67:430-433, 1996
139. ODT, J, Huang PL, Dawson TM, et al: Endothelial NOS and the blockade of LTP by NOS inhibitors in mice lacking neuronal NOS. Science 265:542-546, 1994
140. Huang PL, Dawson TM, Bredt DS, et ai: Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75:1273-1286, 1993
141. Irikura K, Huang PL, Ma J, et al: Cerebrovascular alterations in mice lacking neuronal nitric oxide synthase gene expression. Proc Natl Acad Sci 92:6823-6827, 1995
142. Mashimo H, He XD, Huang PL, et al: Neuronal con-stitutive nitric oxide synthase is involved in murine enteric inhibitory neurotransmission. J Clin Invest 98:8-13, 1996
143. Nelson RJ, Demas GE, Huang PL, et al: Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase. Nature 378:383-386, 1995
144. Laubach VE, Shesely EG, Smithies O, Sherman PA: Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide induced death. Proc Natl Acad Sci 92:10688-10692, 1995
145. Moser M, Pscherer A, Roth C, et al: Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2/J. Genes Dev 11:1938-1948, 1997
146. Hatini V, Huh SO, Herzlinger D, et al: Essential role of stromal mesenchyme in kidney morphogenesis revealed by targeted disruption of Winged Helix transcription factor BF-2. Genes Dev 10:1467-1478, 1996
147. Nakayama K, Nakayama K, Negishi I, et al: Targeted disruption of Bcl-2 alpha-beta in mice: Occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc Natl Acad Sci 91:3700-3704, 1994
148. Lo SH, Yu QC, Degenstein L, et al: Progressive kidney degeneration in mice lacking tensin. J Cell Biol 136:1349-1361, 1997
149. Leveen P, Pekny M, Gebre Medhin S, et al: Mice deficient for PDGF-B show renal, cardiovascular, and hematological abnormalities. Genes Dev 8:1875-1887, 1994